Woo Ian Ying
Director
Exercise
Reported value range
Not reported
13,271 shares
Traded
Oct 15, 2026
Filed
Oct 19, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Novabridge Biosciences
NBP
Transactions reported in official disclosures
33 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Woo Ian Ying Director | Oct 19, 2026 4-day lag | Exercise Oct 15, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Woo Ian Ying Director | Oct 19, 2026 4-day lag | Exercise Oct 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Dennis Phillip Andrew Chief Medical Officer | Sep 21, 2026 3-day lag | Sale Sep 18, 2026 | $5.83K Filed shares x price | SEC Form 4 View filing | |
| Dennis Phillip Andrew Chief Medical Officer | Sep 21, 2026 4-day lag | Exercise Sep 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Dennis Phillip Andrew Chief Medical Officer | Sep 21, 2026 4-day lag | Exercise Sep 17, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Sep 11, 2026 2-day lag | Sale Sep 9, 2026 | $79.9K Filed shares x price | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Sep 8, 2026 5-day lag | Exercise Sep 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Sep 8, 2026 5-day lag | Exercise Sep 3, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Sep 8, 2026 5-day lag | Exercise Sep 3, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Sep 8, 2026 5-day lag | Exercise Sep 3, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Xu Cong Claire EVP, Clinical Development | Sep 1, 2026 1-day lag | Sale Aug 31, 2026 | $2.59K Filed shares x price | SEC Form 4 View filing | |
| Xu Cong Claire EVP, Clinical Development | Sep 1, 2026 2-day lag | Exercise Aug 30, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Xu Cong Claire EVP, Clinical Development | Sep 1, 2026 2-day lag | Exercise Aug 30, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lenz Robert A. Director | Aug 25, 2026 3-day lag | Exercise Aug 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lenz Robert A. Director | Aug 25, 2026 3-day lag | Exercise Aug 22, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Hagler Mark Arnold Chief Commercial Officer | Jul 10, 2026 2-day lag | Award Jul 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lin Liwei Lorraine General Counsel | Jul 10, 2026 2-day lag | Award Jul 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gupta Srishti Chief Executive Officer | Jul 8, 2026 2-day lag | Award Jul 6, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Xu Cong Claire SVP, Clinical Development | Jul 7, 2026 1-day lag | Sale Jul 6, 2026 | $3.99K Filed shares x price | SEC Form 4 View filing | |
| Xu Cong Claire SVP, Clinical Development | Jul 7, 2026 3-day lag | Exercise Jul 4, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Xu Cong Claire SVP, Clinical Development | Jul 7, 2026 3-day lag | Exercise Jul 4, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Fu Wei Director | Jun 30, 2026 1-day lag | Award Jun 29, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Fu Wei Director | Jun 30, 2026 1-day lag | Award Jun 29, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Fu Wei Director | Jun 30, 2026 1-day lag | Award Jun 29, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Fu Wei Director | Jun 30, 2026 1-day lag | Award Jun 29, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Cao Sean Wuxiong Chief Bus. Development Officer | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Dennis Phillip Andrew Chief Medical Officer | Jun 22, 2026 4-day lag | Sale Jun 18, 2026 | $5.61K Filed shares x price | SEC Form 4 View filing | |
| Dennis Phillip Andrew Chief Medical Officer | Jun 22, 2026 5-day lag | Exercise Jun 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Dennis Phillip Andrew Chief Medical Officer | Jun 22, 2026 5-day lag | Exercise Jun 17, 2026 | Not reported Reported range | SEC Form 4 View filing |
Woo Ian Ying
Director
Exercise
Calculated transaction value
$0
5,770 shares @ $0
Traded
Oct 15, 2026
Filed
Oct 19, 2026
Dennis Phillip Andrew
Chief Medical Officer
Sale
Calculated transaction value
$5.83K
8,209 shares @ $0.71
Traded
Sep 18, 2026
Filed
Sep 21, 2026
Dennis Phillip Andrew
Chief Medical Officer
Exercise
Calculated transaction value
$0
10,302 shares @ $0
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Dennis Phillip Andrew
Chief Medical Officer
Exercise
Reported value range
Not reported
23,695 shares
Traded
Sep 17, 2026
Filed
Sep 21, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Sale
Calculated transaction value
$79.9K
107,978 shares @ $0.74
Traded
Sep 9, 2026
Filed
Sep 11, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Exercise
Calculated transaction value
$0
45,320 shares @ $0
Traded
Sep 3, 2026
Filed
Sep 8, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Exercise
Reported value range
Not reported
235,136 shares
Traded
Sep 3, 2026
Filed
Sep 8, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Exercise
Reported value range
Not reported
104,236 shares
Traded
Sep 3, 2026
Filed
Sep 8, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Exercise
Calculated transaction value
$0
102,233 shares @ $0
Traded
Sep 3, 2026
Filed
Sep 8, 2026
Xu Cong Claire
EVP, Clinical Development
Sale
Calculated transaction value
$2.59K
3,282 shares @ $0.79
Traded
Aug 31, 2026
Filed
Sep 1, 2026
Xu Cong Claire
EVP, Clinical Development
Exercise
Reported value range
Not reported
9,382 shares
Traded
Aug 30, 2026
Filed
Sep 1, 2026
Xu Cong Claire
EVP, Clinical Development
Exercise
Calculated transaction value
$0
4,079 shares @ $0
Traded
Aug 30, 2026
Filed
Sep 1, 2026
Lenz Robert A.
Director
Exercise
Calculated transaction value
$0
7,486 shares @ $0
Traded
Aug 22, 2026
Filed
Aug 25, 2026
Lenz Robert A.
Director
Exercise
Reported value range
Not reported
17,218 shares
Traded
Aug 22, 2026
Filed
Aug 25, 2026
Hagler Mark Arnold
Chief Commercial Officer
Award
Calculated transaction value
$0
949,050 shares @ $0
Traded
Jul 8, 2026
Filed
Jul 10, 2026
Lin Liwei Lorraine
General Counsel
Award
Calculated transaction value
$0
254,780 shares @ $0
Traded
Jul 8, 2026
Filed
Jul 10, 2026
Gupta Srishti
Chief Executive Officer
Award
Calculated transaction value
$0
3,000,000 shares @ $0
Traded
Jul 6, 2026
Filed
Jul 8, 2026
Xu Cong Claire
SVP, Clinical Development
Sale
Calculated transaction value
$3.99K
4,485 shares @ $0.89
Traded
Jul 6, 2026
Filed
Jul 7, 2026
Xu Cong Claire
SVP, Clinical Development
Exercise
Reported value range
Not reported
12,432 shares
Traded
Jul 4, 2026
Filed
Jul 7, 2026
Xu Cong Claire
SVP, Clinical Development
Exercise
Calculated transaction value
$0
5,405 shares @ $0
Traded
Jul 4, 2026
Filed
Jul 7, 2026
Fu Wei
Director
Award
Calculated transaction value
$0
1,087,720 shares @ $0
Traded
Jun 29, 2026
Filed
Jun 30, 2026
Fu Wei
Director
Award
Calculated transaction value
$0
1,010,100 shares @ $0
Traded
Jun 29, 2026
Filed
Jun 30, 2026
Fu Wei
Director
Award
Calculated transaction value
$0
725,140 shares @ $0
Traded
Jun 29, 2026
Filed
Jun 30, 2026
Fu Wei
Director
Award
Calculated transaction value
$0
1,087,720 shares @ $0
Traded
Jun 29, 2026
Filed
Jun 30, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Award
Calculated transaction value
$0
181,290 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Cao Sean Wuxiong
Chief Bus. Development Officer
Award
Calculated transaction value
$0
181,280 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Dennis Phillip Andrew
Chief Medical Officer
Sale
Calculated transaction value
$5.61K
8,494 shares @ $0.66
Traded
Jun 18, 2026
Filed
Jun 22, 2026
Dennis Phillip Andrew
Chief Medical Officer
Exercise
Calculated transaction value
$0
10,302 shares @ $0
Traded
Jun 17, 2026
Filed
Jun 22, 2026
Dennis Phillip Andrew
Chief Medical Officer
Exercise
Reported value range
Not reported
23,695 shares
Traded
Jun 17, 2026
Filed
Jun 22, 2026